A landmark city centre office building is open for business. Now complete, The Lumen offers 106,000 sq. ft of grade A office space and is surrounded by the innovative community on Newcastle Helix
Helix-based Iksuda Therapeutics have announced a worldwide license agreement for a new antibody drug.
Despite a difficult end to the financial year, Invest Newcastle ended March 2020 with a record number of new investments and expansions. And Helix was a key part of the success.